We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
-4.27%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.33B
AUM Growth
-$68M
Cap. Flow
+$84.8M
Cap. Flow %
2.55%
Top 10 Hldgs %
70.29%
Holding
301
New
259
Increased
29
Reduced
13
Closed

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$26.3M
2
NVDA icon
NVIDIA
NVDA
+$10.2M
3
AMZN icon
Amazon
AMZN
+$8.1M
4
META icon
Meta Platforms (Facebook)
META
+$5.13M
5
MSFT icon
Microsoft
MSFT
+$4.67M

Sector Composition

Rank Sector Weight
1 Healthcare 5.63%
2 Technology 4.04%
3 Consumer Discretionary 3.1%
4 Communication Services 2.83%
5 Financials 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USIG icon
76
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$2.69K ﹤0.01%
+56
New +$2.75K
PFE icon
77
Pfizer
PFE
$143B
$2.65K ﹤0.01%
+80
New +$2.83K
IYZ icon
78
iShares US Telecommunications ETF
IYZ
$1.22B
$2.45K ﹤0.01%
+115
New +$2.54K
ABT icon
79
Abbott
ABT
$175B
$2.32K ﹤0.01%
+24
New +$2.52K
DHR icon
80
Danaher
DHR
$144B
$2.23K ﹤0.01%
+10
New +$2.23K
AMGN icon
81
Amgen
AMGN
$198B
$2.15K ﹤0.01%
+8
New +$2K
PM icon
82
Philip Morris
PM
$301B
$2.13K ﹤0.01%
+23
New +$2.21K
HD icon
83
Home Depot
HD
$338B
$1.81K ﹤0.01%
+6
New +$1.93K
SO icon
84
Southern Company
SO
$107B
$1.81K ﹤0.01%
+28
New +$1.94K
BMY icon
85
Bristol-Myers Squibb
BMY
$124B
$1.74K ﹤0.01%
+30
New +$1.84K
AVGO icon
86
Broadcom
AVGO
$1.76T
$1.66K ﹤0.01%
+20
New +$1.73K
REGN icon
87
Regeneron Pharmaceuticals
REGN
$70.9B
$1.65K ﹤0.01%
+2
New +$1.57K
ADBE icon
88
Adobe
ADBE
$94.3B
$1.53K ﹤0.01%
+3
New +$1.57K
NFLX icon
89
Netflix
NFLX
$290B
$1.51K ﹤0.01%
+40
New +$1.7K
ISRG icon
90
Intuitive Surgical
ISRG
$122B
$1.46K ﹤0.01%
+5
New +$1.56K
DIS icon
91
Walt Disney
DIS
$170B
$1.46K ﹤0.01%
18
-307,374
-100% -$26.3M
MDLZ icon
92
Mondelez International
MDLZ
$78.3B
$1.46K ﹤0.01%
+21
New +$1.51K
VRTX icon
93
Vertex Pharmaceuticals
VRTX
$123B
$1.39K ﹤0.01%
+4
New +$1.4K
SYK icon
94
Stryker
SYK
$123B
$1.37K ﹤0.01%
+5
New +$1.43K
VZ icon
95
Verizon
VZ
$182B
$1.36K ﹤0.01%
+42
New +$1.42K
MCD icon
96
McDonald's
MCD
$190B
$1.32K ﹤0.01%
+5
New +$1.43K
ELV icon
97
Elevance Health
ELV
$80.9B
$1.31K ﹤0.01%
+3
New +$1.36K
CSCO icon
98
Cisco
CSCO
$441B
$1.29K ﹤0.01%
+24
New +$1.29K
GILD icon
99
Gilead Sciences
GILD
$167B
$1.27K ﹤0.01%
+17
New +$1.31K
CVS icon
100
CVS Health
CVS
$137B
$1.26K ﹤0.01%
+18
New +$1.27K

Similar funds

WestEnd Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, WestEnd Advisors held 301 positions worth $3.33B, down 2% from $3.39B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

WestEnd Advisors's Q3 2023 filing shows 259 new, 29 increased and 13 reduced positions. Its largest new stake was Nike: 296,698 shares worth $28.4M. The largest sale was Walt Disney, an estimated $26.3M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 5.4% a quarter earlier, followed by Technology and Consumer Discretionary.

  • WestEnd Advisors's largest Q3 2023 buy was Nike: 296,698 shares worth $28.4M.
  • WestEnd Advisors added most to State Street Health Care Select Sector SPDR ETF in Q3 2023, an estimated $19.4M increase.
  • WestEnd Advisors's biggest Q3 2023 reduction was Walt Disney, cutting an estimated $26.3M.
  • WestEnd Advisors's ten largest holdings make up 70% of its $3.33B portfolio in Q3 2023.
  • WestEnd Advisors opened 259 new positions and closed 0 in Q3 2023.
  • WestEnd Advisors's portfolio value fell 2% quarter-over-quarter to $3.33B.

Based on WestEnd Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.